cerrar
Tagged with CRO

Ian Wilders – Managing Director, Labo’Life, Spain
Ian Wilders, managing director of Labo’Life, a Spanish micro-immunotherapy specialist, discusses the company’s history and the importance of…

Bertrand Sohier – VP & General Manager Business and…
Bertrand Sohier, VP and general manager business and administration of Parexel France discusses the latest trends impacting the clinical research…

Silvia Casellas – CEO, Anagram, Spain
Silvia Casellas, CEO of Anagram, a Spanish CRO, discusses the challenges of the consolidation process the company has gone in recent years, the…

Lingshi Tan – Founder, Chairman and CEO, dMed, China
Dr Lingshi Tan, chairman and CEO of dMed, shares his strategic insights into the new era of Chinese biotech innovation and how it motivated him to…

Alfonso García Cañamaque – CEO, León Research, Spain
Alfonso García Cañamaque, CEO of León Research, gives an overview of the Spanish clinical research ecosystem and the challenges facing CROs. Also,…

Ji-Young Lee – Senior Director Clinical Operations, PAREXEL…
Ji-Young Lee, senior director clinical operations, and general management & business administration Korea of PAREXEL Korea discusses the strengths…

Top 10 Clinical CROs in Korea
Ten of the top contract research organizations (CROs) currently operating in South Korea, as selected by KoNECT, the Korea National Enterprise for…

George Lee – Vice-President of Clinical Operations and…
George Lee, vice-president of clinical operations and country leader of PAREXEL in China, discusses the impact of the recent ownership and management…

Brian Mi – President, IQVIA Greater China
Brian Mi, president of IQVIA Greater China, shares IQVIA’s leadership position in China in both the commercial and R&D space, building on both…

Sora Lee – Vice President & General Manager Korea,…
Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations for over 10 years. Sora Lee,…

Yangzhou Wang – Chief Operations Officer, CrownBio, China
Dr Yangzhou Wang, chief operations officer of Crown Bioscience (CrownBio), shares the new era of development for the company following its acquisition…

Dan Zhang – Executive Chairman, Fountain Medical…
Dr Dan Zhang, CEO of Fountain Medical Development (FMD), details the transformation China’s recent membership at the International Conference on…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here